Much of what I write about here has to do with the corruption of the medical record by industry funded clinical trials that have distorted both the efficacy and the safety of our treatments – specifically in psychiatry. But the topic has really been the erosion of the medical ethic of the authors and editors […]
Another lightning strike! Awaiting Internet repair…
When Risperdal® [Risperidone] came along in 1994, it was widely hoped [and hyped] that it would release patients from the heavy and sometimes dangerous side effect burden of the earlier neuroleptic medications. One of Janssen’s targeted indications was in to control disruptive behaviors in intellectually impaired children. This RCT was completed in 1998, and used […]
The place of antipsychotics in the treatment of Psychosis remains clouded in controversy in spite of more than a half century of study, experience, and debate. Neither Kraepelin’s Dementia Praecox, a progressive deteriorating illness leading to an early death, nor Bleuler’s Schizophrenia, a defined syndrome with multiple types, survives as the dominant model for predicting […]
South Carolina House votes to remove Confederate flag from statehouse grounds Washington Post By Elahe Izadi and Abby Phillip July 9, 2015 South Carolina Gov. Nikki Haley is set to sign a bill that will bring down the Confederate flag on the statehouse grounds, less than a day after lawmakers in the state House of […]
[click image for the full version] In the 2000 US Census, they asked people to describe their ancestry. The map showing the dominant answer by County had an interesting spot. Instead of some comment about a foreign lineage, they just wrote "American." It’s in yellow and we call it Appalachia for obvious reasons. Outside the […]
Here’s a study that’s likely to engender a brisk discussion: Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study. by Sharifi V, Eaton WW, Wu LT, Roth KB, Burchett BM, and Mojtabai R. British Journal of Psychiatry. 2015 May 7 [Epub ahead of print]. [full […]
Internet hit by lightning. see you next week…
I suppose that if a pharmaceutical company is selling a treatment with a recommended 90 day course at $1,000.00 per pill, we shouldn’t be surprised that the CEO’s yearly salary is beyond obscene… … and even though it’s not a psychiatric drug, I can’t seem to pass up an opportunity to talk about Gilead’s Solvadi® […]
The European Medicines Agency’s Data Transparency policy has made many twists and turns along the way – so many that I summarized them with a timeline last October to serve as a placemarker for the day when the implementation was released. That Timeline is available for review. Tom Jefferson has reported on their recent 2+ […]